Hepatitis C Information - Novelos Therapeutics Closes $15 Million Private Placement

Novelos Therapeutics Closes $15 Million Private Placement
International News Service, Australia - Mar 7, 2006... NOV-002 in lung cancer, in addition to our other clinical development programs, including chemotherapy-resistant ovarian cancer and chronic hepatitis C with NOV ...

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap ...
PR Newswire (press release), NY - Feb 13, 2006... of two monoclonal antibodies against the hepatitis C virus - presently in Phase 1 clinical trials in patients with chronic hepatitis C. XTLbio's hepatitis C ...

Highlights of rising and falling US stocks
Investor's Business Daily (subscription) - Feb 27, 2006... Peregrine Pharmaceuticals Inc. (PPHM) reported positive results related to Tarvacin anti-viral compound in a phase I study of chronic hepatitis C patients. ...

Human Genome Sciences: Human Genome Sciences Reports Financial ...
Webbolt Business News (subscription), Canada - Feb 13, 2006... November 2005, HGS reported the interim results of a Phase 2 trial of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed ...

Nabi Biopharmaceuticals to Present at the Lehman Brothers Ninth ...
PR Newswire (press release), NY - Mar 3, 2006... to prevent hepatitis C disease in HCV-positive liver transplant patients and is being evaluated for the treatment of chronic hepatitis C virus infections. ...